Mapping the chromosomal location of the genes for X-linked lymphoproliferative disease and Waardenburg syndrome. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Mapping the chromosomal location of the genes for X-linked lymphoproliferative disease and Waardenburg syndrome.

Diss Abstr Int [B]; 54(2):658 1993. Unique Identifier : AIDSLINE ICDB/94696674
Wu B; Boston Univ.


Abstract: X-linked lymphoproliferative disease (XLP) is initiated by Epstein-Barr virus infection and results in fatal infectious mononucleosis, severe immunodeficiency and malignant lymphoma. A physical map of the region containing the XLP locus on the X chromosome is necessary for positional cloning of the XLP gene. To confirm a correlation between the genetic linkage map and an XLP deletion, blot hybridization was used to find DNA sequences missing in the XLP male who lacked part of chromosomal band Xq25. Probes corresponding to the deleted sequences were used to identify two additional males with deletions resulting in XLP. The new deletions were also detectable using high resolution G-banding. All three deletions have an overlapping region containing DXS982, DXS739 and DXS75 loci. XLP is the only known consequence of these deletions. To map this XLP candidate gene region physically, fluorescence in situ hybridization (FISH) was employed for high resolution mapping of probes near the XLP locus. Metaphase FISH showed that DXS12 and DXS42 mapped to proximal Xq25, while DXS10 and DXS177 mapped to proximal Xq26.1. DXS6, DXS982, DXS739, DXS75 and DXS100 were in Xq25. The order of probes deduced from metaphase and interphase FISH was as follows: Xq24-(DXS12, DXS42)-DXS6-DXS982-DXS739-DXS75-DXS100-DXS10-DXS177-Xq26.2. This FISH map estimated that the entire region between DXS12 and DXS177 is about 5 megabases (Mb), and confines the XLP locus to a 1.5-Mb interval between DXS6 and DXS100. Field inversion gel electrophoresis (FIGE) was employed to deduce a long range restriction map containing the XLP locus. Sfi I, Sal I, Fsp I and Eag I maps were deduced based on partial and double digestion products. The localization of the 1.5-Mb interval was refined. The FISH and FIGE maps agree in the order and distance between the probes. To physically map the candidate gene region for Waardenburg syndrome type 1 (WS1), FISH was used to localize the PAX3, FN1, ALPI and ALPP genes. FISH and high resolution G-banding showed that two unrelated WS1 patients with interstitial deletion of 2q35-q36.1 and 2q35-q36.2 retained ALPP, ALPI and FN1 on the deleted chromosome 2. FISH also showed that the human PAX3 gene was only absent in the deleted chromosome 2 in both patients. The FISH results confirm the conclusion from linkage analysis and support the contention that mutation of the PAX3 gene causes Waardenburg syndrome. (Full text available from University Microfilms International, Ann Arbor, MI, as Order No. AAD93-17458)
Keywords: Chromosome Banding Chromosome Deletion Chromosome Mapping Human In Situ Hybridization, Fluorescence *Linkage (Genetics) Lymphoproliferative Disorders/*GENETICS Male Waardenburg's Syndrome/*GENETICS *X Chromosome THESISKWDchromosomebandingchromosomedeletionchromosomemappinghumaninsituhybridization,fluorescenceKWDlinkage(genetics)lymphoproliferativedisorders/KWDgeneticsmalewaardenburg'ssyndrome/KWDgeneticsKWDxchromosomethesis
940630
M9460926

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .